Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-24-090850
Filing Date
2024-10-25
Accepted
2024-10-25 17:01:32
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea0217586-02.htm DEFA14A 34529
2 GRAPHIC tproxy_001.jpg GRAPHIC 1547288
3 GRAPHIC tproxy_002.jpg GRAPHIC 673535
  Complete submission text file 0001213900-24-090850.txt   3095102
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-00100 | Film No.: 241397756
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)